US Patent Issued to The Trustees of the University of Pennsylvania, Board of Regents, The University of Texas System on Sept. 9 for "Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor" (Pennsylvania, California, Utah, Texas Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,232, issued on Sept. 9, was assigned to The Trustees of the University of Pennsylvania (Philadelphia) and Board of Regents, The University of Texas System (Austin, Texas).

"Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor" was invented by Nicola Mason (Philadelphia), Daniel J. Powell Jr. (Bala Cynwyd, Pa.), Mohammed Kazim Panjwani (Philadelphia), Jenessa Smith (San Diego), Laurence J.N. Cooper (Park City, Utah) and Colleen M. O'Connor (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compositions and methods for the treatment of a canine CD20 posit...